Myt Enterprises LLC

Myt Enterprises LLC specializes in two primary device categories: skin topical coupling gels and electrode conductive media. These products are formulated to improve signal transmission during electrotherapy and diagnostic procedures by enhancing electrode adhesion and conductivity on the skin.

Myt Enterprises LLC is headquartered in the United States. The company’s location aligns with U.S. regulatory requirements for medical device manufacturing and compliance.

Myt Enterprises LLC’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and compliance with U.S. medical device regulations, particularly for Class II devices.

Myt Enterprises LLC’s devices fall under Class II classification in the U.S. regulatory framework. This classification applies to products that pose moderate risk and require special controls beyond general controls to ensure safety and effectiveness, such as the coupling gels and conductive media in their portfolio.

The FDA’s Unique Device Identifier (UDI) system is mandatory for Class II devices in the U.S. to improve device tracking, reduce medical errors, and enhance post-market surveillance. Myt Enterprises LLC’s products are listed here to comply with these requirements, ensuring transparency and regulatory alignment for their skin topical coupling gels and electrode conductive media.